We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital reduction - notice of completion

2 Jul 2018 14:47

RNS Number : 2971T
Royal Bank of Scotland Group PLC
02 July 2018
 

The Royal Bank of Scotland Group plc

NatWest Markets Plc

 

2 July 2018

Capital reduction - notice of completion

In previous updates on 30 April 2018 and 10 May 2018 on various steps being implemented as part of the ring-fencing strategy of The Royal Bank of Scotland Group plc ("RBSG" and, together with its subsidiaries, "RBS Group"), RBS Group announced its intention to undertake a court-approved capital reduction of NatWest Markets Plc ("NatWest Markets").

NatWest Markets announces that the reduction of its share capital and cancellation of its share premium account and capital redemption reserve (the "Reduction") is now effective following the confirmation of the Reduction by the Court of Session, Edinburgh on 29 June 2018 and the registration of the court order with the Registrar of Companies in Scotland on 2 July 2018. This follows approval of the Reduction by special resolution of NatWest Markets passed at a general meeting of NatWest Markets on 3 May 2018.

As a result of the Reduction, 6,209 million ordinary shares of £1 each in NatWest Markets, the balance of its share premium account (approximately £27,692 million as at 3 May 2018) and the balance of its capital redemption reserve (approximately £0.1 million as at 3 May 2018) have been cancelled.

The Reduction included the return of capital to RBSG in the form of the entire issued share capital of NatWest Holdings Limited (the intermediate holding company of the future ring-fenced sub-group), effectively separating the ring-fenced sub-group from the multiple RBS Group entities outside of the ring-fence, as required by the ring-fencing legislation. A return of capital in cash has also been made to RBSG with the balance of the capital reduced creating distributable reserves.

On a pro forma basis, the Reduction would have caused the NatWest Market's CET1 ratio at 31 May 2018 to reduce from 21.1% to 18.9%, as depicted in the table below. There will continue to be further distributions to RBSG in line with the RBS Group's internal capital management plan and stated capital targets.

31 March 2018

as announced

31 May 2018

actual

post the execution of the First RBS Ring-fencing Transfer Scheme

31 May 2018

pro forma

post Reduction

Risk Weighted Assets

£111.6 billion

£66.8 billion

£52.6 billion

CET 1 Capital

£14.5 billion

£14.1 billion

£9.9 billion

CET 1 Ratio

13.0%

21.1%

18.9%

 

The Reduction does not have any effect on the RBS Group CET1 ratio.

 

Implementation of the Reduction, and thereby creating the legal separation of those RBS Group entities that will be within the ring-fenced sub-group from those held outside the ring-fence, represents the achievement of a further key milestone in our journey to compliance with the ring-fencing legislation.

For further information, please contact:

RBS Investor Relations

 

Matt Waymark

Head of Investor Relations

+44 (0) 20 7672 1758

 

Paul Pybus

Head of Debt Investor Relations

+44 (0) 20 7678 1153

 

 

RBS Media Relations

+44 (0) 13 1523 4205

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including (but not limited to) those related to RBS and its subsidiaries' regulatory capital position, and requirements, financial position, future pension funding and contribution requirements, on-going litigation and regulatory investigations, profitability and financial performance (including financial performance targets), structural reform and the implementation of the UK ring-fencing regime, the implementation of RBS's restructuring and transformation programme, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios, increasing competition from new incumbents and disruptive technologies and RBS's exposure to political risks, operational risk, conduct risk, cyber and IT risk and credit rating risk. In addition, forward-looking statements may include, without limitation, the words "intend", "expect", "anticipate", "target", "plan", "believe", "risk", "estimate", "project", "commit", "should", "could", "probability", "Value-at-Risk (VaR)", "goal", "objective", "may", "endeavour", "outlook", "optimistic", "prospects" and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK 2017 Annual Report and Accounts (ARA) and other materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

MAR - Inside Information

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

 

Legal Entity Identifiers

The Royal Bank of Scotland Group plc

2138005O9XJIJN4JPN90

NatWest Markets Plc

RR3QWICWWIPCS8A4S074

NatWest Holdings Limited

213800GDQMMREYFLQ454

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUCCMUPRGWP
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.